02 November 2021 : Clinical Research
Outcomes from the Use of Perioperative Extracorporeal Membrane Oxygenation in Patients Undergoing Thoracic Surgery: An 8-Year Single-Center Experience
Weizhao Huang1ABDEF*, Hongyu Ye1ACF, Zhou Cheng2AF, Xiaozu Liao2BF, Liqiang Wang2BCD, Binfei Li2CDF, Yi Liang1DFG, Haiming Jiang1DEFGDOI: 10.12659/MSM.931842
Med Sci Monit 2021; 27:e931842
Table 2 Survival rate according to timing and mode of extracorporeal membrane oxygenation.
| Factors | Case | Survived | P-value | |
|---|---|---|---|---|
| Yes | No | |||
| Timing | 0.135 | |||
| Preoperative | 12 | 11 | 1 | |
| Postoperative | 10 | 6 | 4 | |
| Mode | 0.550 | |||
| V-V ECMO | 13 | 11 | 2 | |
| V-A ECMO | 9 | 7 | 2 | |
| V-V ECMO – veno-venous extracorporeal membrane oxygenation; V-A ECMO – veno-arterial extracorporeal membrane oxygenation. | ||||






